Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-005701
Filing Date
2014-08-13
Accepted
2014-08-13 08:44:28
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0614_immucellcorp.htm 10-Q 623471
2 CERTIFICATION f10q0614ex31_immucell.htm EX-31 10038
3 CERTIFICATION f10q0614ex32_immucell.htm EX-32 5892
4 GRAPHIC img1.jpg GRAPHIC 78687
  Complete submission text file 0001213900-14-005701.txt   3373275

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE iccc-20140630.xml EX-101.INS 348346
6 XBRL SCHEMA FILE iccc-20140630.xsd EX-101.SCH 33987
7 XBRL CALCULATION FILE iccc-20140630_cal.xml EX-101.CAL 44396
8 XBRL DEFINITION FILE iccc-20140630_def.xml EX-101.DEF 107100
9 XBRL LABEL FILE iccc-20140630_lab.xml EX-101.LAB 257185
10 XBRL PRESENTATION FILE iccc-20140630_pre.xml EX-101.PRE 185062
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 141035793
SIC: 2835 In Vitro & In Vivo Diagnostic Substances